FDA Approves Label Expansion for Oxlumo

October 7th 2022

This approval for Oxlumo adds lowering plasma oxalate levels for patients with primary hyperoxaluria type 1, a rare and life-threatening metabolic disease.

Capital Blue Cross Teams up with Mark Cuban’s Pharmacy

October 7th 2022

In 2023, Capital Blue Cross members will be able to use their insurance cards at Mark Cuban Cost Plus Drugs. This is the first time the online pharmacy will accept insurance.

EmpiRx Health Lowers Drug Spend in Mental Health

October 7th 2022

EmpiRx Health CEO Karthik Ganesh discusses how the PBM was able to decrease mental health drug spending at a time when utilization is increasing.

Eiger Will Not Submit EUA For COVID-19 Treatment

October 6th 2022

The FDA had indicated that it would not issue an emergency use authorization without additional data for peginterferon lambda to treat patients with mild-to-moderate COVID-19.

UPDATED: UnitedHealthcare Makes Formulary Changes for Medicare Plans

October 6th 2022

UnitedHealthcare is moving more drugs to the lower-cost tiers in its Medicare Advantage plans. Other plans will have $0 copays and insulin at a $25 copay.